Bharat Biotech complete enrollment of 25,800 volunteers for Covaxin Phase-3 trials

The Drug Controller General of India has recently given Emergency Use Authorisation for Covaxin.

Published: 07th January 2021 10:05 PM  |   Last Updated: 07th January 2021 11:04 PM   |  A+A A-

COVID Vaccine

For representational purposes (Photo | AP)

By PTI

HYDERABAD: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin, Suchitra Ella, joint managing director, Bharat Biotech International Ltd said on Thursday.

In a message posted on the company's Twitter account, she thanked clinical trial sites, principal investigators and health workers for their support and trust in the "public- private partnership" vaccine discovery.

"My deep appreciation to all the volunteers for reposing and expressing Pro Vaccine Public Health Voluntarism in the phase-3 clinical trials of India's 1st fully indigenous COVID-19 vaccine," she said referring to Covaxin.

The Drug Controller General of India (DCGI) has recently given Emergency Use Authorisation for Covaxin.

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.

The company had said it is the only Phase-3 efficacy study for a COVID-19 vaccine, and the largest efficacy trial (Phase-3) ever conducted for any vaccine in India.

Now we are on Telegram too. Follow us for updates
India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

Videos
Gallery